18-F-fluoro-D-deoxyglucose positron emission tomography (FDG PET) has become an
established imaging tool in clinical oncology, cardiology and neurology and is now entering …

HIV-infected individuals have a high risk of develo** non-Hodgkin lymphoma (NHL). In
Europe, the prevalence of AIDS with a concurrent NHL diagnosis increased from 3· 6% to 5 …

Background: Persons infected with human immunodeficiency virus (HIV) have an increased
risk for several cancers, but the influences of behavioral risk factors, such as smoking and …

Background: The advent of highly active antiretroviral therapy (HAART) in 1996 led to a
decrease in the incidence of Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma (NHL) …

Background: In the current context of dyslipidaema, hyperglycaema and lipodystrophia
observed among HIV-seropositive subjects, it is important to study the risk of myocardial …

Abstract Effect estimates from randomized trials and observational studies might not be
directly comparable because of differences in study design, other than randomization, and in …

Background The role of exposure to specific antiretroviral drugs on risk of myocardial
infarction in human immunodeficiency virus (HIV)–infected patients is debated in the …

Dynamic treatment regimes are the type of regime most commonly used in clinical practice.
For example, physicians may initiate combined antiretroviral therapy the first time an …

Purpose: To determine incidence of non–AIDS-defining cancers (NADC) in HIV–infected
patients before (P1) and during (P2) the use of highly active antiretroviral therapy (HAART) …

Purpose: To describe the clinical features and outcome of HIV-associated primary effusion
lymphoma (PEL) and to compare them with those of the other HIV-associated non-Hodgkin's …